Stempoint Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-144,467
Closed -$5.35M 52
2024
Q2
$5.35M Buy
+144,467
New +$5.35M 1.57% 21